BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,037 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,418 | -17.2% | 700 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $31,892 | +12.3% | 700 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $28,392 | -20.4% | 700 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $35,679 | -6.1% | 700 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $38,000 | -15.6% | 700 | 0.0% | 0.01% | -22.2% |
| Q2 2022 | $45,000 | -16.7% | 700 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $54,000 | -15.6% | 700 | -6.7% | 0.02% | -14.3% |
| Q4 2021 | $64,000 | +6.7% | 750 | 0.0% | 0.02% | -4.5% |
| Q3 2021 | $60,000 | 0.0% | 750 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $60,000 | -4.8% | 750 | 0.0% | 0.02% | -12.0% |
| Q1 2021 | $63,000 | +5.0% | 750 | 0.0% | 0.02% | -3.8% |
| Q4 2020 | $60,000 | 0.0% | 750 | 0.0% | 0.03% | -13.3% |
| Q3 2020 | $60,000 | -7.7% | 750 | 0.0% | 0.03% | -16.7% |
| Q2 2020 | $65,000 | +8.3% | 750 | 0.0% | 0.04% | -5.3% |
| Q1 2020 | $60,000 | -3.2% | 750 | 0.0% | 0.04% | +26.7% |
| Q4 2019 | $62,000 | -4.6% | 750 | 0.0% | 0.03% | -6.2% |
| Q3 2019 | $65,000 | +6.6% | 750 | 0.0% | 0.03% | +3.2% |
| Q2 2019 | $61,000 | 0.0% | 750 | 0.0% | 0.03% | -3.1% |
| Q1 2019 | $61,000 | +15.1% | 750 | -6.2% | 0.03% | +6.7% |
| Q4 2018 | $53,000 | -14.5% | 800 | 0.0% | 0.03% | -6.2% |
| Q3 2018 | $62,000 | +5.1% | 800 | 0.0% | 0.03% | 0.0% |
| Q2 2018 | $59,000 | +13.5% | 800 | 0.0% | 0.03% | +10.3% |
| Q1 2018 | $52,000 | -10.3% | 800 | -11.1% | 0.03% | -3.3% |
| Q4 2017 | $58,000 | +3.6% | 900 | 0.0% | 0.03% | 0.0% |
| Q3 2017 | $56,000 | +3.7% | 900 | 0.0% | 0.03% | -3.2% |
| Q2 2017 | $54,000 | +14.9% | 900 | 0.0% | 0.03% | +14.8% |
| Q1 2017 | $47,000 | +17.5% | 900 | 0.0% | 0.03% | +12.5% |
| Q4 2016 | $40,000 | -7.0% | 900 | 0.0% | 0.02% | -7.7% |
| Q3 2016 | $43,000 | +4.9% | 900 | 0.0% | 0.03% | -3.7% |
| Q2 2016 | $41,000 | +10.8% | 900 | 0.0% | 0.03% | +3.8% |
| Q1 2016 | $37,000 | -45.6% | 900 | -50.0% | 0.03% | +8.3% |
| Q4 2015 | $68,000 | +126.7% | 1,800 | +100.0% | 0.02% | 0.0% |
| Q3 2015 | $30,000 | -52.4% | 900 | 0.0% | 0.02% | -50.0% |
| Q2 2015 | $63,000 | +1.6% | 900 | 0.0% | 0.05% | +11.6% |
| Q1 2015 | $62,000 | -98.0% | 900 | -97.8% | 0.04% | -98.0% |
| Q4 2014 | $3,051,000 | +0.4% | 41,625 | -1.7% | 2.15% | -9.0% |
| Q3 2014 | $3,038,000 | -0.7% | 42,325 | 0.0% | 2.36% | -1.6% |
| Q2 2014 | $3,060,000 | -5.2% | 42,325 | -3.5% | 2.40% | -6.3% |
| Q1 2014 | $3,228,000 | +9.4% | 43,875 | +3.4% | 2.56% | +5.0% |
| Q4 2013 | $2,951,000 | – | 42,423 | – | 2.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |